Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-17 · accession 0001213900-22-013794 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-21 | 2022-03-17 | BJDX | Kinder Gordon Winston | CFO | P - Purchase | $1.16 | +2,500 | 18.5K | +16% | +$2,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | P | A | 2,500 | $1.16 | 18,500 | D | — | — |